The Spanish pharmaceutical company Almirall is developing a novel treatment for chronic obstructive pulmonary disease (COPD) to be administered by a revolutionary new type of inhaler. Company spokesmen said this week Almirall believes the new treatment aclidinium bromide has potential not only to improve on other medications of its type in relieving symptoms faster and for longer with fewer side effects, but that it will be the easiest bronchodilator to administer. [click link for full article]
(more...)